Release Date: July 31, 2025

Expiration Date: July 31, 2027

Activity Overview

The BURST CME™ format is an inline, on-demand video program designed to deliver concise modular education. In this first module, Dr Aaron D. Berger reviews the limitations of prostate-specific antigen (PSA) testing for the detection of prostate cancer, the plethora of ancillary biomarker tests that are currently available, and how he incorporates biomarker testing into daily practice.

Target Audience

This educational activity is primarily directed toward urologists. Other clinicians who diagnose prostate cancer are welcome to participate as well.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Apply biomarker testing to guide diagnostic evaluation in patients with a high risk of prostate cancer.
Integrate biomarker testing and magnetic resonance imaging to improve risk stratification and early detection in patients with a high risk of prostate cancer.
Implement long-term monitoring strategies for patients with a low risk of prostate cancer.

Guiding Prostate Cancer Diagnosis with Biomarker Testing

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Cleveland Diagnostics.

Guiding Prostate Cancer Diagnosis with Biomarker Testing

GET STARTED WITH THIS PROGRAM:

Related Content